\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\:\\ normal\ \(0\)\
\-\ labs\\:\\ none\ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ multiple\\ bilateral\\ well\\ circumscribed\\ pulmonary\\ nodules\\,\\ without\\ spiculations\\ or\\ irregularities\\.\\ no\\ pathologic\\ lymphadenopathy\\.\ \(0\)\
\-\ benign\\ metastasizing\\ leiomyoma\ \(1\)\
\-\ metastatic\\ malignant\\ tumor\ \(0\)\
\-\ fungal\\ infection\ \(12\)\
\-\ granulomatous\\ diseases\ \(4\)\
\-\ much\\ less\\ likely\\:\\ metastatic\\ benign\\ tumor\\ \\(leiomyoma\\,\\ meningioma\\,\\ pleomorphic\\ adenoma\\,\\ giant\\ cell\\ tumor\\)\ \(0\)\
\-\ 48\\ year\\ old\\ female\\ presents\\ for\\ computed\\ tomography\\ after\\ notifying\\ her\\ primary\\ care\\ provider\\ that\\ years\\ earlier\\ she\\ was\\ told\\ she\\ had\\ a\\ nodule\\ in\\ her\\ lung\\ on\\ chest\\ x\\-ray\\.\ \(0\)\
\-\ surgical\\ history\\:\\ \ \(1\)\
\-\ cholecystectomy\\ at\\ age\\ 35\ \(0\)\
\-\ hysterectomy\\ at\\ age\\ 43\\ \\(for\\ fibroids\\)\ \(0\)\
\-\ benign\\ metastasizing\\ leiomyoma\\ is\\ an\\ extremely\\ rare\\ disorder\\,\\ occuring\\ almost\\ exclusively\\ in\\ women\\ \\(20\\+\\ years\\ of\\ age\\)\\,\\ most\\ of\\ whom\\ have\\ a\\ history\\ of\\ uterine\\ leiomyoma\\ resection\\ or\\ hysterecomy\\ due\\ to\\ large\\ leimyomata\\.\\ lesions\\ which\\ metastasize\\ to\\ the\\ lung\\ may\\ be\\ solitary\\ or\\ multiple\\,\\ appear\\ as\\ well\\ circumscribed\\ rounded\\ lesions\\,\\ and\\ cannot\\ be\\ distinguished\\ from\\ other\\ causes\\ of\\ pulmonary\\ nodules\\ without\\ tissue\\ sampling\\.\\ \ \(0\)\
\-\ patients\\ are\\ usually\\ asymptomatic\\.\\ lesions\\ behave\\ as\\ slow\\ growing\\ benign\\ tumors\\ but\\ some\\ reports\\ refer\\ to\\ them\\ as\\ a\\ low\\ grade\\ sarcoma\\,\\ particularly\\ when\\ found\\ in\\ children\\.\\ lesions\\ are\\ generally\\ quite\\ hormone\\ sensitive\\,\\ though\\ again\\ less\\ so\\ in\\ children\\.\\ \ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ reference\\(s\\)\\:\ \(0\)\
\-\ armstrong\\ p\\.\\ et\\ al\\.\\ imaging\\ of\\ diseases\\ of\\ the\\ chest\\ 3rd\\ edition\\.\\ mosby\\ 2000\\:351\\ \ \(0\)\
\-\ galvin\\ jr\\.\\ et\\ al\\.\\ benign\\ metastasizing\\ leiomyoma\\.\\ the\\ international\\ thoracic\\ teaching\\ resource\\:\\ neoplastic\\ diseases\\.http\\:\\/\\/www\\.vh\\.org\\/adult\\/provider\\/radiology\\/ittr\\/benignmetaleiomyoma\\/bngmetaleiomyoma\\.html\\ \ \(0\)\
\-\ joon\\ beom\\ seo\\.\\ et\\ al\\.\\ atypical\\ pulmonary\\ metastases\\:\\ spectrum\\ of\\ radiologic\\ findings\\.\\ radiographics\\.\\ 2001\\;21\\:403\\-417\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ leiomyoma\\:\\ 0\\.09081820920664688\ \(0\)\
\-\ metastasizing\\:\\ 0\\.0804609104279416\ \(0\)\
\-\ benign\\:\\ 0\\.05323195608363179\ \(0\)\
\-\ al\\:\\ 0\\.03923351884198146\ \(0\)\
\-\ et\\:\\ 0\\.03787796133706442\ \(0\)\
\-\ lesions\\:\\ 0\\.03303336471254798\ \(0\)\
\-\ \\:\\:\\ 0\\.03264331598528997\ \(0\)\
\-\ notifying\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ hysterecomy\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ leimyomata\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ 2000\\:351\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ galvin\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ diseases\\.http\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ \\/\\/www\\.vh\\.org\\/adult\\/provider\\/radiology\\/ittr\\/benignmetaleiomyoma\\/bngmetaleiomyoma\\.html\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ beom\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ seo\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ 21\\:403\\-417\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ diseases\\:\\ 0\\.031080569801080496\ \(0\)\
\-\ spiculations\\:\\ 0\\.029322639867893695\ \(0\)\
\-\ joon\\:\\ 0\\.029322639867893695\ \(0\)\
\-\ age\\:\\ 0\\.028168703886761442\ \(0\)\
\-\ behave\\:\\ 0\\.027858866914434614\ \(0\)\
\-\ resource\\:\\ 0\\.027858866914434614\ \(0\)\
\-\ circumscribed\\:\\ 0\\.027424105322394036\ \(0\)\
\-\ pulmonary\\:\\ 0\\.02703845101321368\ \(0\)\
\-\ 20\\+\\:\\ 0\\.026820303475980533\ \(0\)\
\-\ children\\:\\ 0\\.02665382270442772\ \(0\)\
\-\ armstrong\\:\\ 0\\.026014731088564613\ \(0\)\
\-\ nodules\\:\\ 0\\.02557775354081409\ \(0\)\
\-\ whom\\:\\ 0\\.023892757569062378\ \(0\)\
\-\ sampling\\:\\ 0\\.022854194130608296\ \(0\)\
\-\ teaching\\:\\ 0\\.022854194130608296\ \(0\)\
\-\ occuring\\:\\ 0\\.022565231287021523\ \(0\)\
\-\ metastasize\\:\\ 0\\.02181563069215421\ \(0\)\
\-\ international\\:\\ 0\\.021596769241553366\ \(0\)\
\-\ tumor\\:\\ 0\\.021576523122138747\ \(0\)\
\-\ irregularities\\:\\ 0\\.02139042117714922\ \(0\)\
\-\ exclusively\\:\\ 0\\.021010058304738292\ \(0\)\
\-\ jr\\:\\ 0\\.021010058304738292\ \(0\)\
\-\ less\\:\\ 0\\.02089487367742009\ \(0\)\
\-\ told\\:\\ 0\\.02083392052795334\ \(0\)\
\-\ distinguished\\:\\ 0\\.02083392052795334\ \(0\)\
\-\ hysterectomy\\:\\ 0\\.02050550255609151\ \(0\)\
\-\ p\\.\\:\\ 0\\.020351857738695134\ \(0\)\
\-\ fibroids\\:\\ 0\\.019795357089499258\ \(0\)\
\-\ refer\\:\\ 0\\.01966867362447662\ \(0\)\
\-\ provider\\:\\ 0\\.01898978470208334\ \(0\)\
\-\ them\\:\\ 0\\.01888808478523606\ \(0\)\
\-\ quite\\:\\ 0\\.018599121941649286\ \(0\)\
\-\ her\\:\\ 0\\.018551708725523003\ \(0\)\
\-\ edition\\:\\ 0\\.018418578907083722\ \(0\)\
\-\ mosby\\:\\ 0\\.018163641841329375\ \(0\)\
\-\ years\\:\\ 0\\.018117278967642474\ \(0\)\
\-\ radiographics\\:\\ 0\\.01808251239782014\ \(0\)\
\-\ lung\\:\\ 0\\.01787118498367326\ \(0\)\
\-\ spectrum\\:\\ 0\\.01784952134678198\ \(0\)\
\-\ extremely\\:\\ 0\\.0175605585031952\ \(0\)\
\-\ hormone\\:\\ 0\\.01749179245636959\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.017358069453913456\ \(0\)\
\-\ she\\:\\ 0\\.017319755533965142\ \(0\)\
\-\ growing\\:\\ 0\\.01704394895936606\ \(0\)\
\-\ sensitive\\:\\ 0\\.01675498611577928\ \(0\)\
\-\ slow\\:\\ 0\\.016699868887870298\ \(0\)\
\-\ 43\\:\\ 0\\.01664558052193333\ \(0\)\
\-\ reference\\:\\ 0\\.016592096457727044\ \(0\)\
\-\ tomography\\:\\ 0\\.016487448310170176\ \(0\)\
\-\ cholecystectomy\\:\\ 0\\.016487448310170176\ \(0\)\
\-\ 2001\\:\\ 0\\.0163857483933229\ \(0\)\
\-\ computed\\:\\ 0\\.01628683512910588\ \(0\)\
\-\ radiologic\\:\\ 0\\.016050796287001724\ \(0\)\
\-\ particularly\\:\\ 0\\.01591624251517056\ \(0\)\
\-\ uterine\\:\\ 0\\.015829247744127018\ \(0\)\
\-\ neoplastic\\:\\ 0\\.015786524070311125\ \(0\)\
\-\ metastatic\\:\\ 0\\.015531475838383324\ \(0\)\
\-\ solitary\\:\\ 0\\.015309774171346989\ \(0\)\
\-\ 3rd\\:\\ 0\\.01527274709493114\ \(0\)\
\-\ earlier\\:\\ 0\\.015236095934411222\ \(0\)\
\-\ rounded\\:\\ 0\\.015199813133496052\ \(0\)\
\-\ 48\\:\\ 0\\.015093102656089756\ \(0\)\
\-\ women\\:\\ 0\\.014989456064456431\ \(0\)\
\-\ fungal\\:\\ 0\\.014955558084854123\ \(0\)\
\-\ almost\\:\\ 0\\.014921975439863821\ \(0\)\
\-\ granulomatous\\:\\ 0\\.014888702316741354\ \(0\)\
\-\ giant\\:\\ 0\\.014855733062000295\ \(0\)\
\-\ again\\:\\ 0\\.014823062175646804\ \(0\)\
\-\ chest\\:\\ 0\\.014763386282003745\ \(0\)\
\-\ without\\:\\ 0\\.014527170876232204\ \(0\)\
\-\ though\\:\\ 0\\.014308621516414733\ \(0\)\
\-\ much\\:\\ 0\\.01428052714658782\ \(0\)\
\-\ 35\\:\\ 0\\.014197532495957139\ \(0\)\
\-\ so\\:\\ 0\\.014037056818806114\ \(0\)\
\-\ as\\:\\ 0\\.0139990343598642\ \(0\)\
\-\ well\\:\\ 0\\.01395726319832961\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.013908569652370365\ \(0\)\
\-\ generally\\:\\ 0\\.01388341200140974\ \(0\)\
\-\ disorder\\:\\ 0\\.013858428453234381\ \(0\)\
\-\ sarcoma\\:\\ 0\\.013736040180036976\ \(0\)\
\-\ pathologic\\:\\ 0\\.013503049128998813\ \(0\)\
\-\ atypical\\:\\ 0\\.013370146698952907\ \(0\)\
\-\ metastases\\:\\ 0\\.013179539530841099\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.01311817643925781\ \(0\)\
\-\ multiple\\:\\ 0\\.012994989194796166\ \(0\)\
\-\ adenoma\\:\\ 0\\.012882651089552392\ \(0\)\
\-\ nodule\\:\\ 0\\.012715572560440456\ \(0\)\
\-\ appear\\:\\ 0\\.012625987112354808\ \(0\)\
\-\ reports\\:\\ 0\\.012436391320717818\ \(0\)\
\-\ causes\\:\\ 0\\.012009316598591379\ \(0\)\
\-\ rare\\:\\ 0\\.011979603605318759\ \(0\)\
\-\ thoracic\\:\\ 0\\.011891904354166975\ \(0\)\
\-\ meningioma\\:\\ 0\\.011863138398754783\ \(0\)\
\-\ grade\\:\\ 0\\.011750313331952962\ \(0\)\
\-\ tumors\\:\\ 0\\.011587423673900726\ \(0\)\
\-\ n\\/a\\:\\ 0\\.011174031217902839\ \(0\)\
\-\ malignant\\:\\ 0\\.011150435654798922\ \(0\)\
\-\ care\\:\\ 0\\.011126993310717518\ \(0\)\
\-\ or\\:\\ 0\\.010846816775780225\ \(0\)\
\-\ labs\\:\\ 0\\.010729148039477034\ \(0\)\
\-\ \\(\\:\\ 0\\.01043121626344925\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.010428131400707896\ \(0\)\
\-\ \\)\\:\\ 0\\.010303793387917764\ \(0\)\
\-\ \\,\\:\\ 0\\.009772926552970664\ \(0\)\
\-\ found\\:\\ 0\\.009722114131596073\ \(0\)\
\-\ resection\\:\\ 0\\.009620634135452054\ \(0\)\
\-\ examination\\:\\ 0\\.0095899748573089\ \(0\)\
\-\ be\\:\\ 0\\.009514488977212484\ \(0\)\
\-\ usually\\:\\ 0\\.00936797203562007\ \(0\)\
\-\ some\\:\\ 0\\.00936797203562007\ \(0\)\
\-\ primary\\:\\ 0\\.00913857134619385\ \(0\)\
\-\ infection\\:\\ 0\\.008967568859468618\ \(0\)\
\-\ s\\:\\ 0\\.008847536704384791\ \(0\)\
\-\ when\\:\\ 0\\.008835130821718433\ \(0\)\
\-\ likely\\:\\ 0\\.008701407819262298\ \(0\)\
\-\ low\\:\\ 0\\.00857822401756823\ \(0\)\
\-\ history\\:\\ 0\\.008521404604383274\ \(0\)\
\-\ are\\:\\ 0\\.008410641678914092\ \(0\)\
\-\ at\\:\\ 0\\.008359300742466665\ \(0\)\
\-\ cell\\:\\ 0\\.00833299895877793\ \(0\)\
\-\ due\\:\\ 0\\.008232047483584259\ \(0\)\
\-\ patients\\:\\ 0\\.007984023824426086\ \(0\)\
\-\ none\\:\\ 0\\.007652416992447677\ \(0\)\
\-\ physical\\:\\ 0\\.007568611081520716\ \(0\)\
\-\ bilateral\\:\\ 0\\.007486706604023264\ \(0\)\
\-\ tissue\\:\\ 0\\.007311989850009364\ \(0\)\
\-\ \\;\\:\\ 0\\.007311989850009364\ \(0\)\
\-\ imaging\\:\\ 0\\.007227703337384848\ \(0\)\
\-\ most\\:\\ 0\\.007122148526094138\ \(0\)\
\-\ other\\:\\ 0\\.0071106084790702115\ \(0\)\
\-\ can\\:\\ 0\\.0069971926081915875\ \(0\)\
\-\ may\\:\\ 0\\.006766528407574454\ \(0\)\
\-\ large\\:\\ 0\\.006745640548126642\ \(0\)\
\-\ have\\:\\ 0\\.006680281871354122\ \(0\)\
\-\ had\\:\\ 0\\.006656497542385229\ \(0\)\
\-\ but\\:\\ 0\\.006579434299760064\ \(0\)\
\-\ findings\\:\\ 0\\.006566198324151479\ \(0\)\
\-\ surgical\\:\\ 0\\.006484555127261565\ \(0\)\
\-\ after\\:\\ 0\\.006382675821693872\ \(0\)\
\-\ female\\:\\ 0\\.006342094842771963\ \(0\)\
\-\ presents\\:\\ 0\\.006301964965732584\ \(0\)\
\-\ in\\:\\ 0\\.006085158557982021\ \(0\)\
\-\ which\\:\\ 0\\.0057586447192871796\ \(0\)\
\-\ that\\:\\ 0\\.00532845028360586\ \(0\)\
\-\ for\\:\\ 0\\.005264318762763286\ \(0\)\
\-\ normal\\:\\ 0\\.0048361460454841194\ \(0\)\
\-\ to\\:\\ 0\\.004625286373028732\ \(0\)\
\-\ from\\:\\ 0\\.004571970083589214\ \(0\)\
\-\ not\\:\\ 0\\.004457829139862582\ \(0\)\
\-\ a\\:\\ 0\\.004295304712836837\ \(0\)\
\-\ an\\:\\ 0\\.004265938138212021\ \(0\)\
\-\ was\\:\\ 0\\.0035677888888580754\ \(0\)\
\-\ year\\:\\ 0\\.0034516435713823636\ \(0\)\
\-\ old\\:\\ 0\\.0031586086529323274\ \(0\)\
\-\ no\\:\\ 0\\.0031062965729379134\ \(0\)\
\-\ of\\:\\ 0\\.0029441393703462776\ \(0\)\
\-\ on\\:\\ 0\\.002613324954387827\ \(0\)\
\-\ \\.\\:\\ 0\\.002178671890450854\ \(0\)\
\-\ is\\:\\ 0\\.0020299306078870962\ \(0\)\
\-\ the\\:\\ 0\\.0014972846718804237\ \(0\)\
\-\ and\\:\\ 0\\.0006498520062534962\ \(0\)\
